Co‐targeting the PI3K/ mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms
Author:
Affiliation:
1. Department of Experimental and Clinical Medicine University of Florence Florence Italy
2. Inserm, U.1009 Institut Gustave Roussy and Université Paris XI Villejuif France
Publisher
Wiley
Subject
Cell Biology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12162
Reference51 articles.
1. Advances in Understanding and Management of Myeloproliferative Neoplasms
2. Improving Survival Trends in Primary Myelofibrosis: An International Study
3. New mutations and pathogenesis of myeloproliferative neoplasms
4. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders
5. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hematopoietic colony-stimulating factors in head and neck cancers: Recent advances and therapeutic challenges;Cytokine;2024-01
2. Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasms;2023-10-25
3. Lysosomal Degradation Pathways Target Mutant Calreticulin and the Thrombopoietin Receptor in Myeloproliferative Neoplasms;2023-07-12
4. The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors;Expert Opinion on Pharmacotherapy;2023-06-26
5. PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis;Clinical Cancer Research;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3